Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919283 | Radiotherapy and Oncology | 2012 | 6 Pages |
Abstract
The design of preoperative concurrent boost IMRT with oral capecitabine could achieve high rate of ypCR with an acceptable toxicity profile.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jin-luan Li, Jia-fu Ji, Yong Cai, Xiao-fan Li, Yong-heng Li, Hao Wu, Bo Xu, Fang-yuan Dou, Zi-yu Li, Zhao-de Bu, Ai-wen Wu, Ivan W.K. Tham,